中国当代医药2024,Vol.31Issue(12) :185-189,194.

中药治疗慢性萎缩性胃炎的作用机制研究进展

Research progress on the mechanism of traditional Chinese medicine in the treatment of chronic atrophic gastritis

林海辰 周明
中国当代医药2024,Vol.31Issue(12) :185-189,194.

中药治疗慢性萎缩性胃炎的作用机制研究进展

Research progress on the mechanism of traditional Chinese medicine in the treatment of chronic atrophic gastritis

林海辰 1周明1
扫码查看

作者信息

  • 1. 南京中医药大学中医学院·中西医结合学院,江苏南京 210023
  • 折叠

摘要

慢性萎缩性胃炎(CAG)是一种临床常见的慢性消化系统疾病,在我国发病率较高.该疾病的发病与幽门螺杆菌(Hp)感染、十二指肠液反流、免疫损伤等多种因素有密切联系,发病机制复杂.针对此病,西医目前尚无疗效理想的治疗药物,而在传统中医理论的指导下,中医药在CAG的临床治疗中表现出其具有的独特优势,尤其是在减轻胃黏膜炎症、修复胃黏膜损伤、延缓或逆转胃黏膜肠化及异型增生等方面具有显著的治疗效果.本文经文献整理,梳理出研究较为广泛,与中药治疗CAG起效密切相关的TLR4/NF-κ B、PI3K/AKT、JAK/STAT、Hedgehog及Wnt/β-catenin信号通路,并分析作用机制,以期为深入探索中药治疗CAG的药效机制提供研究思路,同时为该疾病的临床药物选择与应用,以及新药的开发和研究提供参考方向.

Abstract

Chronic atrophic gastritis(CAG)is a common chronic digestive system disease in clinical practice,which has a high incidence rate in China.Its pathogenesis is related to Helicobacter pylori(Hp)infection,duodenal reflux,immune in-jury and other factors,and its mechanism is complex.At present,there is no ideal therapeutic drug for this disease in western medicine,while under the guidance of traditional Chinese medicine theory,Chinese medicine has its unique advantages,which especially plays a significant role in reducing gastric mucosal inflammation,repairing gastric mucosal damage,delaying or reversing intestinal metaplasia and dysplasia of gastric mucosa.This paper sorts out TLR4/NF-K B、PI3K/AKT.JAK/STAT、Hedgehog and Wnt/β-catenin signaling pathways,which have been widely studied and are closely related to the effect of traditional Chinese medicine on CAG.It analyzes the mechanism of action,in order to provide research ideas for further exploring the pharmacodynamic mechanism of traditional Chinese medicine in the treatment of CAG,and provide reference directions for the clinical drug selection and new drug development of the disease.

关键词

慢性萎缩性胃炎/中药/信号通路/综述

Key words

Chronic atrophic gastritis/Traditional Chinese medicine/Signal pathway/Review

引用本文复制引用

基金项目

江苏省科技计划(BK20210687)

出版年

2024
中国当代医药
中国保健协会 当代创新(北京)医药科学研究院

中国当代医药

影响因子:1.215
ISSN:1674-4721
参考文献量44
段落导航相关论文